With a vote in the lead European Parliament committee imminent on European Commission plans to revamp copyright rules, industry stakeholders, digital rights activists and even some EU member states are troubled by various legislative amendments and EU …Continue Reading ...
Perhaps the most debated issue in obviousness disputes is the question of whether a person of ordinary skill in the art would have been motivated to combine prior art references in order to form the invention as claimed. In KSR, the Supreme Court made the process a little bit easier for patent examiners by permitting […]Continue Reading ...
Publicly financed software should be open source, more than 30 signatories of an open letter are proclaiming, calling for others to sign the letter.Continue Reading ...
For the last two years, World Intellectual Property Organization delegates have been trying to tackle a seemingly unsolvable equation: too many candidate countries for four new WIPO external offices. Yet more time seems necessary to reduce the number o…Continue Reading ...
A few dozen amici briefs have been filed in the case, including one filed on August 30th by 39 patent owners affected by PTAB activities in support of the petitioner Oil States. These patent owners have either already or are currently faced PTAB validi…Continue Reading ...
The key idea is to think strategically about the software, the value it can provide to the company, and whether the technology should be developed in-house. In some cases, software can provide more value to the company when it includes open source comp…Continue Reading ...
The tribe is raising a sovereign immunity defense in the case as the tribe is a sovereign entity which is not amenable to a suit unless it consents or Congress abrogates its immunity. Shore argued that the sovereign immunity defense is based on binding Supreme Court precedent. “It would frankly be unprecedented for the board to deny the tribe the right to seek a dismissal before conducting the hearing on the merits,” Shore said… On seven occasions during the call, Torczon called the sale of…
Continue Reading ...
Guest post by Professor Greg Ablavsky, Stanford Law School
In Property, I frequently hedge my answers to student questions by cautioning that I am not an expert in intellectual property. I’m writing on an IP blog today because, with Allergan’s deal with the Saint Regis Mohawk Tribe, IP scholars have suddenly become interested in an area of law I do know something about: federal Indian law.
Two principles lie at the core of federal Indian law. First, tribes possess inherent sovereignty, although their authority can be restricted through treaty, federal statute, or when inconsistent with their dependent status. Second, Congress possesses plenary power over tribes, which means it can alter or even abolish tribal sovereignty at will.
Tribal sovereign immunity flows from tribes’ sovereign status. Although the Supreme Court at one point described tribal sovereign immunity as an “accident,” the doctrine’s creation in the late nineteenth century in fact closely paralleled contemporaneous rationales for the development of state, federal, and foreign sovereign immunity. But the Court’s tone is characteristic of its treatment of tribal sovereign immunity: even as the Court has upheld the principle, it has done so reluctantly, even hinting to Congress that it should cabin its scope. This language isn’t surprising. The Court hasn’t been a friendly place for tribes for nearly forty years, with repeated decisions imposing ever-increasing restrictions on tribes’ jurisdiction and authority. What is surprising is that tribal sovereign immunity has avoided this fate. The black-letter law has remained largely unchanged, narrowly surviving a 2014 Court decision that saw four Justices suggest that the doctrine should be curtailed or even abolished.
So let me now turn to the Allergan deal and briefly discuss its doctrinal and normative implications. First, the doctrinal. I don’t profess any insight into the IP-specific aspects of the dispute, but tribal sovereign immunity is robust. Unlike foreign sovereign immunity, there is no commercial-activity exception to tribal immunity. The lower courts have instead crafted an “arm of the tribe” test to determine if an entity may benefit from the tribe’s immunity, looking toward whether the entity is chartered under tribal law, whether its proceeds serve to further the aims of tribal self-governance, and whether the tribe intended to confer its immunity. Tribal casinos and other commercial enterprises routinely receive the benefit of sovereign immunity under this test, and I assume Allergan’s attorneys were smart enough to engineer the deal accordingly. The Court did carve out a possible workaround last Term in the wonderfully named Lewis v. Clarke when it declined to extend tribal sovereign immunity to a tribal employee sued for damages in his individual capacity. But the Court’s decision said nothing about the argument of the United States as amicus curiae that official immunity should still be available, so this issue remains undetermined. As for waiver, the Court’s jurisprudence holds that the tribe’s intent to relinquish immunity must be “clear.” This principle has generally made lower courts to be reluctant to find constructive waiver, although there is some case law that voluntary participation in bankruptcy proceedings waives tribal immunity.
Now the normative. Many scholars are not fans of sovereign immunity in general, and their hackles may be raised still further by what may seem like tribes renting their immunity. It’s worth noting that the drug companies are latecomers to this particular scheme: payday lenders have been setting up in Indian country for a while to avail themselves of tribal immunity. There are good reasons to question whether exploiting what outsiders might read as a loophole is ultimately a wise strategic move on tribes’ part. It’s especially risky in an area of law where the federal government’s persistent tendency is to craft blanket policy for all 567 federally recognized tribes despite significant differences among them.
But it’s also worth pausing to think about why a tribe might engage in this particular enterprise. Popular imagination might envision casino riches, but Indian gaming revenue is spread very unevenly, with only a handful of well-situated tribes bringing in large sums. For the majority of reservations, some of the highest poverty and unemployment rates in the nation remain the norm. This reality is inseparable from centuries of colonial dispossession and violence. But it is also the perverse result of federal law, which allows states to tax businesses within Indian country as long as states provide de minimis services. As a result, tribes—often forced onto remote lands—face the choice of imposing double taxation on reservation businesses or foregoing their own tax revenue. Tribal leaders are understandably anxious to make deals that will bring much-needed jobs and money to places that have long lacked both.
If tribal sovereign immunity dramatically distorts patent law, there is a remedy available. Unlike in the state context, Congress can readily use its plenary power to abrogate tribal sovereign immunity in patent law. But I’d also urge IP scholars to look around during their virtual sojourn in Indian country. They might discover that immunity is but a small part of a patchwork of complex laws, many of which disadvantage Native peoples. To lawyers, these areas seem distinct—sovereign immunity seems distant from the criminal law complexities of jurisdiction, for instance, that have contributed both to an epidemic of sexual violence against indigenous women and some of the highest incarceration rates of any racial minority in the nation. But these issues are less much distinct for the people who experience these daily realities, and they help explain why tribal governments are scrounging for resources to try to provide desperately needed services for their citizens.Continue Reading ...
A law review article shows that the impact post-eBay on the granting of injunctions varies by industry type.
From Table 1:
Table 1. Industry classification and injunction grant rate by industry
Industry Sector Grant Rate
Chemistry /Chemical 88.9%
Consumer Goods 81.0%
Medical Devices 46.2%
from The Unintended Consequences of the Injunction Law after eBay v. MercExchange: An Empirical Study of the Effects on Injunctions in Patent Law
99 J. Pat. & Trademark Off. Soc’y 249 (2017)
One recalls in 2006 LBE wrote an article titled “Will there be Unintended Consequences from the Supreme Court Decision in eBay v. MercExchange?”
In 27 Rev. Litig. 1 (2007), Douglas Laycock wrote:
in eBay Inc. v. MercExchange, L.L.C., n6 where the Court substantially rearranged the standards for granting permanent injunctions without appearing to realize it had changed anything. Recognizing that there can be sound reasons for limiting or refusing injunctive relief, Professor Rendleman would treat those reasons as in the nature of affirmative defenses to plaintiff’s prima facie entitlement to an injunction ordering defendant to obey the law. My own view is that his proposal states what the law has been in practice for a long time, n7 and that the Court’s opinion has now moved formal doctrine further from reality than it was before. Litigators and trial judges would be much better off if the eBay opinion could have been assigned to Professor Rendleman.
In Modern American Remedies: Cases and Materials at 426 (4th ed. 2010) Douglas Laycock argued that there was “no traditional four-part test” and that the Supreme Court majority’s citations supporting this test are misplaced in cases related to preliminary injunctions.
One notes also the text in 27 Rev. Litig. 161 (2008) :
Continue Reading ...
in a very different context, the Supreme Court’s decision in eBay Inc. v. MercExchange, L.L.C. n13 is a spectacular example of the confusion that can result from litigating a remedies issue without a remedies specialist. But the reality is that except for consulting opportunities for law professors, the practice of law does not support remedies specialists. It is only teachers and students who have the freedom to consider remedies apart from underlying questions about liability, and thus only law professors who can specialize in remedies.
As to the law:”A Rule 59(e) motion calls into question the correctness of a judgment.” Templetv. Hydrochem Inc., 367 F.3d 473, 478 (5th Cir. 2004). There are three grounds foraltering or amending a judgment under Rule 59(e): “(1) an intervening change …Continue Reading ...
There is both an issue of “argument not made” AND improper referencing in the brief:Defendant makes the new claim construction argument that if a material serves more thanone function, such as, as both a dispersant and a carrier, then that material wou…Continue Reading ...
$$ FIGS. 6a and 6b show a tetrahedron produced with three traps in a first plane (Z=0) and a single trap (Z=1) in a second plane. …Continue Reading ...
To say Brexit is a conundrum is almost a euphemism, the list of issues to settle between the 27 remaining European Union members and the United Kingdom seems bottomless. Intellectual property is no exception, and the European Commission Brexit-dedicated taskforce just issued a position paper on IP, setting out principles for a “UK’s orderly withdrawal from the EU.”Continue Reading ...
As a placeholder – I’ll note here that the pending en banc case of In re Aqua Products regarding amendments during IPR Proceedings is still pending before the Federal Circuit. The court asked two questions: (a) When the patent owner moves to amend its claims under 35 U.S.C. § 316(d), may the PTO require the patent […]Continue Reading ...
Following institution of inter partes review, the United
States Patent Trial and Appeal Board found every
claim of U.S. Patent No. 8,366,268 (“’268 patent”) unpatentable
as obvious. Cablz, Inc., the owner of the ’268
patent, appeals from this decision, arguing that substantial
evidence fails to support the Board’s obviousness
determination and that the Board failed to adequately
explain a motivation to combine the prior art. Finding no
error in the Board’s decision, we affirm
The technology relates to holding eyeglasses on:
The ’268 patent is entitled “Eye Wear Retention Device.”
As the patent explains, people have long been using
devices like chains, strings, and ropes to retain their
glasses around their necks. A significant problem is that
such devices rest directly against the wearer’s back or
neck, which can cause the device to become entangled
with clothing or coated with sweat or suntan lotion. The
’268 patent purports to solve the problem and discloses an
eyewear retainer that “extends rearward from the head of
the wearer and is suspended off the neck of the wearer.”
J.A. 40 at Abstract.
The cited prior art in this case is of interest.
The topic of waiver arose:
As an initial matter, we conclude that Cablz waived
its argument that Monroe fails to disclose a “resilient”
cable or member because it failed to raise this argument
in its briefing before the IPR oral hearing. The court
retains case-by-case discretion over whether to apply
waiver. In re Nuvasive, Inc., 842 F.3d 1376, 1380 (Fed.
As a result, we do not have the
benefit of the Board’s informed judgment on the specific
reading of Monroe that Cablz advances on appeal. The
argument is thus waived. See Watts, 354 F.3d at 1368.
Query: when the Board, or other trial court, ignores
an argument actually presented, the reviewing court is also deprived of
the benefit. Does the reviewing court then vacate?
Of motivation to combine:
Continue Reading ...
We may affirm the Board’s ruling if we reasonably
discern that it followed a proper path, even if that path is
less than perfectly clear. Nuvasive, 842 F.3d at 1383
(citing Bowman Transp., Inc. v. Ark.-Best Freight Sys.,
Inc., 419 U.S. 281, 285–86 (1974)); Ariosa Diagnostics v.
Verinata Health, Inc., 805 F.3d 1359, 1365 (Fed. Cir.
The Board’s decision provides a reasonably discernable
path for articulating a motivation to combine the prior
“one of skilled in the art would have ‘immediately recognized
that a simple substitution of the eyewear retainers
of Mackay for the attachment method employed in Monroe
would have had various advantages.’” Chums, 2016
WL 763054 at *5. The Board similarly summarized
Appellee’s arguments regarding a motivation to combine
the other prior art references. Id. at *5–6. After analyzing
the arguments, the Board concluded that achieving
the ’268 patent’s configuration required only “simple
substitution.” Id. at *11.
The Board also addressed and rejected each of Cablz’s
arguments that there was no motivation to combine the
prior art. First, the Board found no persuasive reason
why the cited combinations “taught away” from the ’268
patent’s invention. Id. at *8. Second, the Board rejected
Cablz’s argument that Mr. Sosin failed to recognize and
solve the “being in the way problem.” Id. at *8–9. Third,
the Board found the age of the references and the fact
that Appellees did not combine the references to create
their own product did not preclude a motivation to combine
the prior art. Id. at *9–10. Ultimately, the Board
concluded that Appellees provided “strong evidence of
obviousness.” Id. at *15. Taken together, we may reasonably
discern that the Board found a motivation to
combine the references because doing so would have been
a matter of simple substitution that would result in an
eyeglass retainer with certain advantages.
Post grant procedures can be an effective and efficient way of promoting patent quality by invalidating weak, inappropriately granted patents. What we need now is thoughtful review and assessment, based upon five years of experience about what is work…Continue Reading ...
The chart above provides an update to my prior post – looking at patents issued over the past 40 years and finding the proportion of patents that use the word “SAID” within the patent claims. During this time, there has been a general trend in legal writing toward the use of Plain English rather than legalese, and I […]Continue Reading ...
- Breaking – WHO Issues Alarming Report On Coming Shortage Of Antibiotics
- Judge Paul Michel presents supplemental testimony on PTAB reforms to the House IP subcommittee
- Access To Generic Reproductive Health Supplies Decades Behind Medicines?
- Access To Generic Reproductive Health Supplies Decades Behind Medicines?
- The Most Interesting Man in the Patent World Fights to Improve America’s Patent System